全文获取类型
收费全文 | 16487篇 |
免费 | 1382篇 |
国内免费 | 399篇 |
专业分类
耳鼻咽喉 | 227篇 |
儿科学 | 476篇 |
妇产科学 | 391篇 |
基础医学 | 2013篇 |
口腔科学 | 232篇 |
临床医学 | 1830篇 |
内科学 | 2710篇 |
皮肤病学 | 167篇 |
神经病学 | 1259篇 |
特种医学 | 560篇 |
外国民族医学 | 1篇 |
外科学 | 1477篇 |
综合类 | 1739篇 |
现状与发展 | 4篇 |
一般理论 | 13篇 |
预防医学 | 1759篇 |
眼科学 | 387篇 |
药学 | 1293篇 |
8篇 | |
中国医学 | 430篇 |
肿瘤学 | 1292篇 |
出版年
2024年 | 42篇 |
2023年 | 272篇 |
2022年 | 480篇 |
2021年 | 912篇 |
2020年 | 620篇 |
2019年 | 667篇 |
2018年 | 668篇 |
2017年 | 548篇 |
2016年 | 581篇 |
2015年 | 692篇 |
2014年 | 835篇 |
2013年 | 937篇 |
2012年 | 1288篇 |
2011年 | 1272篇 |
2010年 | 725篇 |
2009年 | 570篇 |
2008年 | 864篇 |
2007年 | 983篇 |
2006年 | 836篇 |
2005年 | 810篇 |
2004年 | 611篇 |
2003年 | 526篇 |
2002年 | 464篇 |
2001年 | 236篇 |
2000年 | 210篇 |
1999年 | 258篇 |
1998年 | 174篇 |
1997年 | 118篇 |
1996年 | 89篇 |
1995年 | 95篇 |
1994年 | 74篇 |
1993年 | 55篇 |
1992年 | 61篇 |
1991年 | 78篇 |
1990年 | 64篇 |
1989年 | 62篇 |
1988年 | 54篇 |
1987年 | 50篇 |
1986年 | 39篇 |
1985年 | 47篇 |
1984年 | 24篇 |
1983年 | 18篇 |
1982年 | 18篇 |
1981年 | 21篇 |
1980年 | 20篇 |
1976年 | 12篇 |
1975年 | 13篇 |
1974年 | 21篇 |
1972年 | 12篇 |
1971年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
941.
942.
943.
Anna Börje Ann‐Therese Karlberg Carola Lidén Suresh Rastogi David Roberts Ian R. White 《Contact dermatitis》2013,69(4):196-230
Contact allergy to fragrances is still relatively common, affecting ~ 16% of patients patch tested for suspected allergic contact dermatitis, considering all current screening allergens. The objective of the review is to systematically retrieve, evaluate and classify evidence on contact allergy to fragrances, in order to arrive at recommendations for targeting of primary and secondary prevention. Besides published evidence on contact allergy in humans, animal data (local lymph node assay), annual use volumes and structure–activity relationships (SARs) were considered for an algorithmic categorization of substances as contact allergens. A total of 54 individual chemicals and 28 natural extracts (essential oils) can be categorized as established contact allergens in humans, including all 26 substances previously identified as contact allergens (SCCNFP/0017/98). Twelve of the 54 individual chemicals are considered to be of special concern, owing to the high absolute number of reported cases of contact allergy (> 100). Additionally, 18 single substances and one natural mixture are categorized as established contact allergens in animals. SARs, combined with limited human evidence, contributed to the categorization of a further 26 substances as likely contact allergens. In conclusion, the presence of 127 single fragrance substances and natural mixtures should, owing to their skin sensitizing properties, be disclosed, for example on the label. As an additional preventive measure, the maximum use concentration of 11 substances of special concern should be limited to 100 ppm. The substance hydroxyisohexyl 3‐cyclohexene carboxaldehyde and the two ingredients chloroatranol and atranol in the natural extracts Evernia prunastri and Evernia furfuracea should not be present in cosmetic products. 相似文献
944.
945.
Joseph T. F. Lau Annisa L. Lee Wai S. Tse Phoenix K. H. Mo Francois Fong Zixin Wang Linda D. Cameron Vivian Sheer 《AIDS and behavior》2016,20(9):1851-1862
Fear appeal approach has been used in health promotion, but its effectiveness has been mixed. It has not been well applied to HIV prevention among men who have sex with men (MSM). The present study developed and evaluated the relative efficacy of three online interventions (SC: STD-related cognitive approach, SCFI: STD-related cognitive plus fear appeal imagery approach, Control: HIV-related information based approach) in reducing prevalence of unprotected anal intercourse (UAI) among 396 MSM using a randomized controlled trial design. Participants’ levels of fear-related emotions immediately after watching the assigned intervention materials were also assessed. Participants were evaluated at baseline and 3 months after the intervention. Results showed that participants in the SCFI scored significantly higher in the instrument assessing fear after the watching the intervention materials. However, no statistically significant differences were found across the three groups in terms of UAI at Month 3. Some significant within-group reductions in some measures of UAI were found in three groups. Further studies are warranted to test the role of fear appeal in HIV prevention. 相似文献
946.
947.
Colin N. Haile Therese A. Kosten Thomas R. Kosten 《The American journal of drug and alcohol abuse》2013,39(4):355-381
Aims: Psychiatric pharmacogenetics involves the use of genetic tests that can predict the effectiveness of treatments for individual patients with mental illness such as drug dependence. This review aims to cover these developments in the pharmacotherapy of alcohol and opiates, two addictive drugs for which we have the majority of our FDA approved pharmacotherapies. Methods: We conducted a literature review using Medline searching terms related to these two drugs and their pharmacotherapies crossed with related genetic studies. Results: Alcohol's physiological and subjective effects are associated with enhanced β-endorphin release. Naltrexone increases baseline β-endorphin release blocking further release by alcohol. Naltrexone's action as an alcohol pharmacotherapy is facilitated by a putative functional single nucleotide polymorphism (SNP) in the opioid mu receptor gene (Al18G) which alters receptor function. Patients with this SNP have significantly lower relapse rates to alcoholism when treated with naltrexone. Caucasians with various forms of the CYP2D6 enzyme results in a ‘poor metabolizer’ phenotype and appear to be protected from developing opioid dependence. Others with a “ultra-rapid metabolizer” phenotype do poorly on methadone maintenance and have frequent withdrawal symptoms. These patients can do well using buprenorphine because it is not significantly metabolized by CYP2D6. Conclusions: Pharmacogenetics has great potential for improving treatment outcome as we identify gene variants that affect pharmacodynamic and pharmacokinetic factors. These mutations guide pharmacotherapeutic agent choice for optimum treatment of alcohol and opiate abuse and subsequent relapse. 相似文献
948.
D Gu K Reynolds X Duan X Xin J Chen X Wu J Mo PK Whelton J He;for the InterASIA Collaborative Group 《Diabetologia》2012,55(10):2861-2862
949.
950.